Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial

DOI Full Paper Access

556

Citations

23

References

2020

Year

Franck Morschhauser, Hervé Tilly, Aristeidis Chaidos, Pam McKay, Tycel Phillips, Sarit Assouline, Connie Lee Batlevi, Phillip L. Campbell, Vincent Ribrag, Gandhi Damaj,

The Lancet Oncology

Lymphoid NeoplasiaOncologyMalignant Blood DisorderRefractory Follicular LymphomaDermatologyPhase 2ImmunotherapyMedicineRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1